This antibody binds to HER2-expressing cancer cells through its anti-HER2 arm, whereas its second arm attaches to CD63, directing endocytosis-mediated transport of the drug payload directly to tumor cells, resulting in their destruction 125. The gene discussed is ERBB2; the disease is cancer.